OTCMKTS:DOCMF Dr. Martens (DOCMF) Stock Price, News & Analysis $0.90 0.00 (0.00%) As of 05/20/2026 12:22 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort InterestBuy This Stock About Dr. Martens Stock (OTCMKTS:DOCMF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Dr. Martens alerts:Sign Up Key Stats Today's Range$0.90▼$0.9250-Day Range$0.82▼$0.9352-Week Range$0.76▼$1.36Volume400 shsAverage Volume26,288 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Dr. Martens, traded on the OTCMKTS as DOCMF, is a global footwear and fashion brand best known for its iconic leather boots and shoes. Founded in 1947 by German engineer Klaus Märtens, the company has built a reputation for durable, air-cushioned soles and distinctive yellow stitching. Over the decades, Dr. Martens has expanded its product line to include a wide range of footwear styles, leather jackets, apparel and accessories, all designed to reflect its heritage of rebellious youth culture and practical functionality. The company’s core business activities span design, manufacturing and marketing. Dr. Martens maintains quality control through a network of factory partners in Asia and Europe, ensuring each product meets its stringent specifications for comfort and durability. In addition to its classic 1460 boot, the brand offers loafers, sandals and seasonal collections that cater to diverse consumer preferences. Product categories also extend to branded socks, laces and shoe-care items, supporting the longevity of each pair. Dr. Martens serves customers in more than 60 countries, with a strong presence in the United Kingdom, Europe, North America and Asia Pacific regions. Distribution channels include direct-to-consumer outlets such as company-owned retail stores and e-commerce sites, as well as wholesale partnerships with specialty footwear and fashion retailers. This multi-channel approach allows Dr. Martens to maintain brand control while reaching a broad demographic of consumers, from long-time enthusiasts to new adopters. Under the leadership of Chief Executive Officer Kenny Wilson, appointed in 2019, Dr. Martens has focused on expanding its global retail footprint and enhancing digital engagement. The management team emphasizes brand authenticity and community connection, leveraging collaborations with artists and designers to drive product innovation. As of its most recent corporate disclosures, Dr. Martens continues to pursue balanced growth strategies that reinforce its heritage while adapting to evolving market trends.AI Generated. May Contain Errors. Read More Receive DOCMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOCMF Stock News HeadlinesBerenberg Bank Remains a Buy on Dr. Martens Plc (DOCS)May 22 at 6:42 PM | theglobeandmail.comDr Martens' turnaround gathers pace as annual profit jumps 61%May 19, 2026 | reuters.comSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500. | Brownstone Research (Ad)Dr. Martens Reshapes Leadership to Drive Consumer‑First GrowthApril 24, 2026 | theglobeandmail.comDr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call TranscriptJanuary 27, 2026 | seekingalpha.comDr. Martens Revenue Drops on Europe, Middle East and Africa WeaknessJanuary 27, 2026 | wsj.comBerenberg Bank Reiterates Dr. Martens (DOCMF) Buy RecommendationNovember 30, 2025 | msn.comPeel Hunt Limited Reiterates Dr. Martens (DOCMF) Buy RecommendationNovember 22, 2025 | msn.comSee More Headlines DOCMF Stock Analysis - Frequently Asked Questions How have DOCMF shares performed this year? Dr. Martens' stock was trading at $1.03 at the start of the year. Since then, DOCMF stock has decreased by 12.3% and is now trading at $0.9033. How do I buy shares of Dr. Martens? Shares of DOCMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryN/A Current SymbolOTCMKTS:DOCMF CIKN/A Webwww.drmartensplc.com Phone44-12-1415-7047FaxN/AEmployees2,591Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:DOCMF) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Martens With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.